Cubist Systematic Strategies’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $361K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $14.5M | Buy |
|
|||||
|
2023
Q4 | $10.7M | Buy |
|
|||||
|
2023
Q3 | $5.82M | Sell |
|
|||||
|
2023
Q2 | $10.1M | Buy |
|
|||||
|
2023
Q1 | $800K | Sell |
|
|||||
|
2022
Q4 | $10.1M | Buy |
|
|||||
|
2022
Q3 | $4.92M | Buy |
|
|||||
|
2022
Q2 | $1.03M | Sell |
|
|||||
|
2022
Q1 | $4.18M | Buy |
|
|||||
|
2021
Q4 | $1.53M | Sell |
|
|||||
|
2021
Q3 | $3.2M | Sell |
|
|||||
|
2021
Q2 | $8.71M | Buy |
|
|||||
|
2021
Q1 | $1.68M | Buy |
|
|||||
|
2020
Q4 | $539K | Sell |
|
|||||
|
2020
Q3 | $2.85M | Buy |
|
|||||
|
2020
Q2 | $133K | Buy |
|